3
Most read
4
Most read
11
Most read
SEVERITY AND SERIOUSNESS
ASSESSMENT OF ADR
Dr. Ramesh Bhandari
Asst. Professor
Department of Pharmacy Practice,
KLE College of Pharmacy, Belagavi
SEVERITY
•The term severity is often used to describe the
intensity of a medical event.
•Severity assessment categorizes the ADRs as
mild, moderate or severe based on the steps taken
for the management of the ADRs.
SEVERITY
• KARCH AND LASAGNA classified severity into minor, moderate,
severe and lethal as defined below:
 Minor: No antidote, treatment or prolongation of hospitalization
required.
 Moderate: A change in drug therapy (e.g.: modified dosage, addition
of a drug), but not necessarily discontinuation of the drug is required;
hospitalization may be prolonged, or specific treatment may be
required.
 Severe: Potentially life threatening, causing permanent damage or
requiring intensive medical care. Requires drug discontinuation.
 Lethal: Directly or indirectly contributes to the death of the patient.
MODIFIED HARTWIG’S AND SIEGELASSESSMENT SCALE
• Hartwig et. al robustly categorized ADR severity into seven
levels according to clinical consequence, including resultant
harm and intensity of medical intervention required.
oLevel 1 and 2 fall under mild category
oLevel 3 and 4 fall under moderate category
oLevel 5, 6 and 7 fall under category severe category.
Modified Hartwig and Siegel
• Mild:
Level 1: The ADR requires no change in treatment with the
suspected drug
Level 2: The ADR requires that the suspected drug be withheld,
discontinued or otherwise changed. NO antidote or other
treatment is required, and there is no increase in length of stay.
Modified Hartwig and Siegel
• Moderate:
Level 3: The ADR requires that the suspected drug be withheld,
discontinued or otherwise changed, and / or an antidote or
other treatment is required. There is no increase in length of
stay
Level 4 (a): Any level 3 ADR that increases length of stay by at
least one day
Level 4 (b): The ADR is the reason for admission.
Modified Hartwig and Siegel
• Severe:
Level 5: Any level 4 ADR that requires intensive medical care.
Level 6: The ADR causes permanent harm to the patient
Level 7: The ADR either directly or indirectly leads to the death
of the patient.
SERIOUSNESS CLASSIFICATION
• A serious adverse event or reaction is any untoward medical
occurrence that at any dose:
 Results in death
 Is life threatening
 Requires inpatient hospitalization or prolong hospitalization
 Results in persistent or significant disability
 Is a congenital anomaly/birth defect
PREVENTABILITY AND
PREDICTABILITY OF ADRs
PREVENTABILITY OFADRs
• Schumock and Thornton criteria:
• It has three sections namely definitely preventable, probably preventable and not-preventable.
• Section A comprises of five questions while section B has four questions.
• All the answers are categorized as “yes” or “no”.
• ADRs are “definitely preventable” if answer was “yes” to one or more questions in section A.
• If answers are all negative (“no”), then proceed to section B
• ADRs are “probably preventable” if answer was “yes” to one or more questions in section B.
• If answers were all negative then proceed to section C.
• In section C, the ADRs are not-preventable.
Severity, seriousness, predictability and preventability assessment
PREDICTABILITY Of ADRs
• Type A (Predictable):
Extension of pharmacological effect
Often predictable and dose dependent
Example: Dry mouth induced by anti-cholinergics.
• Type B (Non-predictable):
Idiosyncratic or immunologic reactions
Rare and unpredictable
Example: Penicillin induced anaphylactic shock.
REFERENCES
1. Karch FE, Lasagna L. Adverse drug reactions. JAMA. 1975;
234(12):1236
2. S. K. Gupta. Textbook of Pharmacovigilance. 2nd Edition. Jaypee
Brothers Medical Publishers. 2019.
THANK YOU

More Related Content

PPTX
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
PPTX
Detection and Reporting of Adverse Reaction
PPTX
Establishment of Pharmacovigilance Programme
PDF
Predictabilty and Preventability Assessment, Management of ADR, Terminologies...
PPTX
Basic terminologies used in pharmacovigilance.pptx
PPTX
Establishing Pharmacovigilance Centres In Hospital.pptx
PPTX
Methods and Tools for ADR Reporting.pptx
PPT
Detection, reporting and management of adverse events
SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR’S
Detection and Reporting of Adverse Reaction
Establishment of Pharmacovigilance Programme
Predictabilty and Preventability Assessment, Management of ADR, Terminologies...
Basic terminologies used in pharmacovigilance.pptx
Establishing Pharmacovigilance Centres In Hospital.pptx
Methods and Tools for ADR Reporting.pptx
Detection, reporting and management of adverse events

What's hot (20)

PPTX
Regulatory terminologies used in PV (Pharmacovigilance)
PPTX
WHO International Drug Monitoring Program
PPTX
Establish Pharmacovigilance Centres in hospital and National Programmes.pptx
PPTX
CIOMS (1).pptx
PPTX
Vaccine safety surveillance
PDF
ICH Guidelines for Pharmacovigilance
PPTX
2.3  Daily defined doses.pptx
PPTX
Investigational new drug (IND)
PPTX
Adverse drug reactions
PPTX
1.2 Importance of safety monitoring of Medicine.pptx
PPTX
Active and passive survillance
PPTX
Ppt On National Programmes Related to Pharmacovigilance
PPTX
History and development of pharmacovigilance.pptx
PPTX
Management of adverse drug reactions
PPTX
Pharmacovigilance program of India (PvPI)
PDF
Safety Data Generation
PPTX
Methods of causality assessment
PPTX
Safety monitoring in clinical trails
PPTX
Clinical Trail and Pharmacovigilance
Regulatory terminologies used in PV (Pharmacovigilance)
WHO International Drug Monitoring Program
Establish Pharmacovigilance Centres in hospital and National Programmes.pptx
CIOMS (1).pptx
Vaccine safety surveillance
ICH Guidelines for Pharmacovigilance
2.3  Daily defined doses.pptx
Investigational new drug (IND)
Adverse drug reactions
1.2 Importance of safety monitoring of Medicine.pptx
Active and passive survillance
Ppt On National Programmes Related to Pharmacovigilance
History and development of pharmacovigilance.pptx
Management of adverse drug reactions
Pharmacovigilance program of India (PvPI)
Safety Data Generation
Methods of causality assessment
Safety monitoring in clinical trails
Clinical Trail and Pharmacovigilance
Ad

Similar to Severity, seriousness, predictability and preventability assessment (20)

PPTX
Severity & preventability Assesment .pptx
PPTX
ADVERSE DRUG REACTION
DOCX
Causality assessment scales
PPTX
Severity and seriousness assessment: Pharmacovigilance aspects.
PPTX
Introduction to Adverse drug Reaction
PPTX
Adverse Event & Reporting system and Forms.pptx
PPTX
Advesre drug reaction- Types, Reporting, Evaluation, Monitoring, Preventing &...
PPTX
Detection, reporting and monitoring of ad rs final ppt
PPTX
Adverse Drug Reactions.pptx
PPTX
OVERVIEW OF ADR.pptx
PPTX
ADR and pharmacovigillance
PPTX
severity and seriousness.pptx
PPTX
Adverse drug reactions
PPTX
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
PPTX
Pharmacovigilance aspects : Predictability & Preventability Assessment.pptx
PPTX
triage ppt.pptx
PPTX
ADR by Mukesh Jaiswal & Somya Verma
PPT
Adverse_Drug_Reactions_Pharmacology_.ppt
Severity & preventability Assesment .pptx
ADVERSE DRUG REACTION
Causality assessment scales
Severity and seriousness assessment: Pharmacovigilance aspects.
Introduction to Adverse drug Reaction
Adverse Event & Reporting system and Forms.pptx
Advesre drug reaction- Types, Reporting, Evaluation, Monitoring, Preventing &...
Detection, reporting and monitoring of ad rs final ppt
Adverse Drug Reactions.pptx
OVERVIEW OF ADR.pptx
ADR and pharmacovigillance
severity and seriousness.pptx
Adverse drug reactions
The Prospective Study Of Adverse Drug Reactions in Surgical Wards of a Tertia...
Pharmacovigilance aspects : Predictability & Preventability Assessment.pptx
triage ppt.pptx
ADR by Mukesh Jaiswal & Somya Verma
Adverse_Drug_Reactions_Pharmacology_.ppt
Ad

More from Dr. Ramesh Bhandari (20)

PDF
Designing Protocol.pdf
PDF
Communicable diseases
PDF
Causality Assessment ADR.pdf
PDF
Microbiological culture sensitivity tests
PDF
Respiratory and Intestinal infections
PDF
Epidemiology
PDF
Microbiology
PDF
Nutrition and Food
PDF
Effect of environment on health
PDF
Vaccine and immunity
PDF
Psychosocial pharmacy
PDF
PDF
Mother and child health
PDF
Demography, demographic cycle and family planning methods
PDF
National health policy, MDGs, SDPs, and FIP Development Goals
PDF
Concept, Dimension, Determinants, and Indicators of health
PDF
Social pharmacy, National Health Mission
PDF
Pharmacovigilance methods
PPTX
Detection and monitoring of ADRs
PPTX
Adverse drug reactions
Designing Protocol.pdf
Communicable diseases
Causality Assessment ADR.pdf
Microbiological culture sensitivity tests
Respiratory and Intestinal infections
Epidemiology
Microbiology
Nutrition and Food
Effect of environment on health
Vaccine and immunity
Psychosocial pharmacy
Mother and child health
Demography, demographic cycle and family planning methods
National health policy, MDGs, SDPs, and FIP Development Goals
Concept, Dimension, Determinants, and Indicators of health
Social pharmacy, National Health Mission
Pharmacovigilance methods
Detection and monitoring of ADRs
Adverse drug reactions

Recently uploaded (20)

PDF
FYJC - Chemistry textbook - standard 11.
PPT
hsl powerpoint resource goyloveh feb 07.ppt
PPTX
4. Diagnosis and treatment planning in RPD.pptx
PDF
Compact First Student's Book Cambridge Official
PDF
Kalaari-SaaS-Founder-Playbook-2024-Edition-.pdf
PDF
Unleashing the Potential of the Cultural and creative industries
DOCX
THEORY AND PRACTICE ASSIGNMENT SEMESTER MAY 2025.docx
PDF
Health aspects of bilberry: A review on its general benefits
PPTX
Power Point PR B.Inggris 12 Ed. 2019.pptx
PPTX
ACFE CERTIFICATION TRAINING ON LAW.pptx
PPTX
2025 High Blood Pressure Guideline Slide Set.pptx
PPTX
Cite It Right: A Compact Illustration of APA 7th Edition.pptx
PDF
Disorder of Endocrine system (1).pdfyyhyyyy
PPTX
ENGlishGrade8_Quarter2_WEEK1_LESSON1.pptx
PDF
GIÁO ÁN TIẾNG ANH 7 GLOBAL SUCCESS (CẢ NĂM) THEO CÔNG VĂN 5512 (2 CỘT) NĂM HỌ...
PPTX
Theoretical for class.pptxgshdhddhdhdhgd
PPTX
Neurology of Systemic disease all systems
PPTX
IT infrastructure and emerging technologies
PDF
Diabetes Mellitus , types , clinical picture, investigation and managment
PPTX
Math 2 Quarter 2 Week 1 Matatag Curriculum
FYJC - Chemistry textbook - standard 11.
hsl powerpoint resource goyloveh feb 07.ppt
4. Diagnosis and treatment planning in RPD.pptx
Compact First Student's Book Cambridge Official
Kalaari-SaaS-Founder-Playbook-2024-Edition-.pdf
Unleashing the Potential of the Cultural and creative industries
THEORY AND PRACTICE ASSIGNMENT SEMESTER MAY 2025.docx
Health aspects of bilberry: A review on its general benefits
Power Point PR B.Inggris 12 Ed. 2019.pptx
ACFE CERTIFICATION TRAINING ON LAW.pptx
2025 High Blood Pressure Guideline Slide Set.pptx
Cite It Right: A Compact Illustration of APA 7th Edition.pptx
Disorder of Endocrine system (1).pdfyyhyyyy
ENGlishGrade8_Quarter2_WEEK1_LESSON1.pptx
GIÁO ÁN TIẾNG ANH 7 GLOBAL SUCCESS (CẢ NĂM) THEO CÔNG VĂN 5512 (2 CỘT) NĂM HỌ...
Theoretical for class.pptxgshdhddhdhdhgd
Neurology of Systemic disease all systems
IT infrastructure and emerging technologies
Diabetes Mellitus , types , clinical picture, investigation and managment
Math 2 Quarter 2 Week 1 Matatag Curriculum

Severity, seriousness, predictability and preventability assessment

  • 1. SEVERITY AND SERIOUSNESS ASSESSMENT OF ADR Dr. Ramesh Bhandari Asst. Professor Department of Pharmacy Practice, KLE College of Pharmacy, Belagavi
  • 2. SEVERITY •The term severity is often used to describe the intensity of a medical event. •Severity assessment categorizes the ADRs as mild, moderate or severe based on the steps taken for the management of the ADRs.
  • 3. SEVERITY • KARCH AND LASAGNA classified severity into minor, moderate, severe and lethal as defined below:  Minor: No antidote, treatment or prolongation of hospitalization required.  Moderate: A change in drug therapy (e.g.: modified dosage, addition of a drug), but not necessarily discontinuation of the drug is required; hospitalization may be prolonged, or specific treatment may be required.  Severe: Potentially life threatening, causing permanent damage or requiring intensive medical care. Requires drug discontinuation.  Lethal: Directly or indirectly contributes to the death of the patient.
  • 4. MODIFIED HARTWIG’S AND SIEGELASSESSMENT SCALE • Hartwig et. al robustly categorized ADR severity into seven levels according to clinical consequence, including resultant harm and intensity of medical intervention required. oLevel 1 and 2 fall under mild category oLevel 3 and 4 fall under moderate category oLevel 5, 6 and 7 fall under category severe category.
  • 5. Modified Hartwig and Siegel • Mild: Level 1: The ADR requires no change in treatment with the suspected drug Level 2: The ADR requires that the suspected drug be withheld, discontinued or otherwise changed. NO antidote or other treatment is required, and there is no increase in length of stay.
  • 6. Modified Hartwig and Siegel • Moderate: Level 3: The ADR requires that the suspected drug be withheld, discontinued or otherwise changed, and / or an antidote or other treatment is required. There is no increase in length of stay Level 4 (a): Any level 3 ADR that increases length of stay by at least one day Level 4 (b): The ADR is the reason for admission.
  • 7. Modified Hartwig and Siegel • Severe: Level 5: Any level 4 ADR that requires intensive medical care. Level 6: The ADR causes permanent harm to the patient Level 7: The ADR either directly or indirectly leads to the death of the patient.
  • 8. SERIOUSNESS CLASSIFICATION • A serious adverse event or reaction is any untoward medical occurrence that at any dose:  Results in death  Is life threatening  Requires inpatient hospitalization or prolong hospitalization  Results in persistent or significant disability  Is a congenital anomaly/birth defect
  • 10. PREVENTABILITY OFADRs • Schumock and Thornton criteria: • It has three sections namely definitely preventable, probably preventable and not-preventable. • Section A comprises of five questions while section B has four questions. • All the answers are categorized as “yes” or “no”. • ADRs are “definitely preventable” if answer was “yes” to one or more questions in section A. • If answers are all negative (“no”), then proceed to section B • ADRs are “probably preventable” if answer was “yes” to one or more questions in section B. • If answers were all negative then proceed to section C. • In section C, the ADRs are not-preventable.
  • 12. PREDICTABILITY Of ADRs • Type A (Predictable): Extension of pharmacological effect Often predictable and dose dependent Example: Dry mouth induced by anti-cholinergics. • Type B (Non-predictable): Idiosyncratic or immunologic reactions Rare and unpredictable Example: Penicillin induced anaphylactic shock.
  • 13. REFERENCES 1. Karch FE, Lasagna L. Adverse drug reactions. JAMA. 1975; 234(12):1236 2. S. K. Gupta. Textbook of Pharmacovigilance. 2nd Edition. Jaypee Brothers Medical Publishers. 2019.